The Medical College of Virginia/Virginia Commonwealth University School of Medicine is the largest and oldest continuously operating medical school in Virginia.

During the past decade, Medical College of Virginia conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 10 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medical College of Virginia" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 12 trials, followed by "Virginia Commonwealth University" with 9 trials sponsored, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 3 trials sponsored, "Advanz Pharma" with 2 trials sponsored and "Glaxo Wellcome" with 2 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medical College of Virginia" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 8 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 4 trials as a collaborator, "Astellas Pharma US, Inc." with 2 trials as a collaborator, "Medtronic" with 2 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator. Other collaborators include 32 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Medical College of Virginia" are "HIV Infections" (16 trials), "Obesity" (4 trials), "Liver Cirrhosis" (3 trials), "Alcoholism" (2 trials) and "Diabetes Mellitus, Type 2" (2 trials). Many other conditions were trialed in "Medical College of Virginia" in a lesser frequency.

Most popular intervention types in "Medical College of Virginia" are "Drug" (46 trials), "Device" (6 trials), "Behavioral" (5 trials), "Other" (5 trials) and "Genetic" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Nevirapine" (5 trials), "Ritonavir" (5 trials), "Zidovudine" (5 trials) and "Didanosine" (4 trials). Other intervention names were less common.

The vast majority of trials in "Medical College of Virginia" are 67 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Medical College of Virginia". undefined are not yet recruiting, 5 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 55 completed trials in Medical College of Virginia, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Medical College of Virginia, 6 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 13 trials that are defined as “Not Applicable".